Amgen (AMGN) Common Equity (2009 - 2026)
Amgen (AMGN) posted Common Equity of $11.69 billion for Q2 2026, up 57.4% from $7.43 billion a year earlier and up 27.2% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Amgen's Common Equity came in at $8.66 billion, up 47.3% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
- In prior years, Amgen's Common Equity was $5.88 billion in FY2024 (-5.7%), $6.23 billion in FY2023 (+70.2%), $3.66 billion in FY2022 (-45.4%) and $6.7 billion in FY2021 (-28.8%).
- The Q2 2026 figure stands as the highest quarterly Common Equity since Q4 2018.
- On a year-over-year basis, Common Equity has increased in each of the last six quarters, with growth averaging 27.8% over the last eight quarters.
- The strongest year-over-year quarter for Common Equity in the past five years was Q1 2023, with growth of 483.8%; the weakest was Q1 2022, with a decline of 90.2%.
- According to Business Quant data, Common Equity for the three prior quarters was $9.19 billion (Q1 2026), $8.66 billion (Q4 2025) and $9.62 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 22.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.69 Bn |
| Mar 31, 2026 | 9.19 Bn |
| Dec 31, 2025 | 8.66 Bn |
| Sep 30, 2025 | 9.62 Bn |
| Jun 30, 2025 | 7.43 Bn |
| Mar 31, 2025 | 6.21 Bn |
| Dec 31, 2024 | 5.88 Bn |
| Sep 30, 2024 | 7.53 Bn |
| Jun 30, 2024 | 5.93 Bn |
| Mar 31, 2024 | 5.02 Bn |
| Dec 31, 2023 | 6.23 Bn |
| Sep 30, 2023 | 7.66 Bn |
| Jun 30, 2023 | 6.78 Bn |
| Mar 31, 2023 | 5.35 Bn |
| Dec 31, 2022 | 3.66 Bn |
| Sep 30, 2022 | 3.65 Bn |
| Jun 30, 2022 | 2.42 Bn |
| Mar 31, 2022 | 916.00 Mn |
| Dec 31, 2021 | 6.70 Bn |
| Sep 30, 2021 | 8.22 Bn |
API Access
Amgen Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();